Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 2
2010 4
2011 7
2012 6
2013 3
2014 3
2015 6
2016 8
2017 5
2018 10
2019 8
2020 14
2021 13
2022 14
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J, de la Espriella R, Miñana G, Santas E, Llácer P, Núñez E, Palau P, Bodí V, Chorro FJ, Sanchis J, Lupón J, Bayés-Genís A. Núñez J, et al. Among authors: palau p. Eur J Heart Fail. 2021 Sep;23(9):1445-1457. doi: 10.1002/ejhf.2295. Epub 2021 Jul 20. Eur J Heart Fail. 2021. PMID: 34241936 Free article. Review.
The emerging role of carbohydrate antigen 125 in heart failure.
Santas E, Palau P, Bayés-Ge A, Núñez J. Santas E, et al. Among authors: palau p. Biomark Med. 2020 Mar;14(4):249-252. doi: 10.2217/bmm-2019-0470. Epub 2020 Mar 3. Biomark Med. 2020. PMID: 32125176 No abstract available.
Sex differences on peak oxygen uptake in heart failure.
Palau P, Domínguez E, Núñez J. Palau P, et al. ESC Heart Fail. 2019 Oct;6(5):921-926. doi: 10.1002/ehf2.12483. Epub 2019 Jul 19. ESC Heart Fail. 2019. PMID: 31325239 Free PMC article. Review.
Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status.
Lorenzo M, Jacobs-Cachá C, Palau P, Amiguet M, Seller J, Núñez E, Espriella R, Górriz JL, Miñana G, Sanchis J, Bayés-Genis A, Soler MJ, Packer M, Núñez J; DAPA-VO2 Investigators. Lorenzo M, et al. Among authors: palau p. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. JACC Heart Fail. 2023. PMID: 37676213 Clinical Trial.
Dapagliflozin and short-term changes on circulating antigen carbohydrate 125 in heart failure with reduced ejection fraction.
Amiguet M, Palau P, Domínguez E, Seller J, Pinilla JMG, de la Espriella R, Miñana G, Valle A, Sanchis J, Górriz JL, Bayés-Genís A; DAPA VO2 investigators; Núñez J. Amiguet M, et al. Among authors: palau p. Sci Rep. 2023 Jun 30;13(1):10591. doi: 10.1038/s41598-023-37491-5. Sci Rep. 2023. PMID: 37391470 Free PMC article. Clinical Trial.
Short-term effects of dapagliflozin on maximal functional capacity in heart failure with reduced ejection fraction (DAPA-VO2 ): a randomized clinical trial.
Palau P, Amiguet M, Domínguez E, Sastre C, Mollar A, Seller J, Garcia Pinilla JM, Larumbe A, Valle A, Gómez Doblas JJ, de la Espriella R, Miñana G, Mezcua AR, Santas E, Bodí V, Sanchis J, Pascual-Figal D, Górriz JL, Baýes-Genís A, Núñez J; DAPA-VO2 Investigators (see Appendix). Palau P, et al. Eur J Heart Fail. 2022 Oct;24(10):1816-1826. doi: 10.1002/ejhf.2560. Epub 2022 Jun 6. Eur J Heart Fail. 2022. PMID: 35604416 Free article. Clinical Trial.
98 results